Douglas Lane & Associates LLC acquired a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 169,977 shares of the company's stock, valued at approximately $3,034,000. Douglas Lane & Associates LLC owned about 0.51% of Grail as of its most recent filing with the Securities & Exchange Commission.
Analyst Ratings Changes
GRAL has been the subject of a number of recent research reports. Guggenheim assumed coverage on shares of Grail in a research note on Thursday, October 17th. They set a "neutral" rating for the company. Wolfe Research began coverage on shares of Grail in a research note on Friday, November 15th. They set a "peer perform" rating for the company. Finally, Morgan Stanley initiated coverage on Grail in a research report on Wednesday, November 27th. They issued an "equal weight" rating and a $16.00 price target on the stock.
Check Out Our Latest Research Report on Grail
Insider Activity
In other Grail news, CFO Aaron Freidin sold 30,452 shares of the firm's stock in a transaction on Monday, November 18th. The stock was sold at an average price of $14.02, for a total value of $426,937.04. Following the completion of the sale, the chief financial officer now owns 268,277 shares of the company's stock, valued at approximately $3,761,243.54. This trade represents a 10.19 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Robert P. Ragusa sold 123,454 shares of the company's stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $14.02, for a total transaction of $1,730,825.08. Following the transaction, the chief executive officer now directly owns 612,661 shares in the company, valued at approximately $8,589,507.22. This trade represents a 16.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here.
Grail Price Performance
NASDAQ:GRAL traded down $0.21 during midday trading on Thursday, reaching $17.66. The stock had a trading volume of 828,560 shares, compared to its average volume of 601,978. The business's fifty day simple moving average is $17.88. Grail, Inc. has a 12-month low of $12.33 and a 12-month high of $24.92.
Grail Company Profile
(
Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Read More
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
